Cargando…

Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis

Osteoporosis is a bone disease characterized by increasing osseous fragility and fracture due to the reduced bone mass and microstructural degradation. Primary pharmacological strategies for the treatment of osteoporosis, hormone replacement treatment (HRT), and alendronate therapies may produce adv...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jianbo, Li, Xiaojuan, Wang, Ziyi, Bennett, Samuel, Chen, Kai, Xiao, Zhifeng, Zhan, Jiheng, Chen, Shudong, Hou, Yu, Chen, Junhao, Wang, Shaofang, Xu, Jiake, Lin, Dingkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886594/ https://www.ncbi.nlm.nih.gov/pubmed/31824310 http://dx.doi.org/10.3389/fphar.2019.01344

Ejemplares similares

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
por: He, Jianbo, et al.
Publicado: (2021)

Growth Factors and Anticatabolic Substances for Prevention and Management of Intervertebral Disc Degeneration
por: Longo, Umile Giuseppe, et al.
Publicado: (2012)

Polydatin promotes the neuronal differentiation of bone marrow mesenchymal stem cells in vitro and in vivo: Involvement of Nrf2 signalling pathway
por: Zhan, Jiheng, et al.
Publicado: (2020)

Sodium Tanshinone IIA Silate Exerts Microcirculation Protective Effects against Spinal Cord Injury In Vitro and In Vivo
por: Li, Xing, et al.
Publicado: (2020)

Coenzyme Q10 Regulation of Apoptosis and Oxidative Stress in H(2)O(2) Induced BMSC Death by Modulating the Nrf-2/NQO-1 Signaling Pathway and Its Application in a Model of Spinal Cord Injury
por: Li, Xing, et al.
Publicado: (2019)

Fasudil Promotes BMSC Migration via Activating the MAPK Signaling Pathway and Application in a Model of Spinal Cord Injury
por: Zhan, Jiheng, et al.
Publicado: (2018)

Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species
por: Chen, Delong, et al.
Publicado: (2021)

Accuracy and Safety of Robot-Assisted versus Fluoroscopy-Guided Posterior C1 Lateral Mass and C2 Pedicle Screw Internal Fixation for Atlantoaxial Dislocation: A Preliminary Study
por: Zhan, Jiheng, et al.
Publicado: (2022)

Polydatin Attenuates OGD/R-Induced Neuronal Injury and Spinal Cord Ischemia/Reperfusion Injury by Protecting Mitochondrial Function via Nrf2/ARE Signaling Pathway
por: Zhan, Jiheng, et al.
Publicado: (2021)

Effects of anabolic-androgens on brain reward function
por: Mhillaj, Emanuela, et al.
Publicado: (2015)

A review of anabolic therapies for osteoporosis
por: Lane, Nancy E, et al.
Publicado: (2003)

Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
por: Hong, Guoju, et al.
Publicado: (2020)

Anabolic Androgenic Steroids: Searching New Molecular Biomarkers
por: Sessa, Francesco, et al.
Publicado: (2018)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
por: Wang, Gang, et al.
Publicado: (2022)

Anabolic therapy for osteoporosis: update on efficacy and safety
por: Bandeira, Leonardo, et al.
Publicado: (2022)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
por: Yang, Xue, et al.
Publicado: (2021)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
por: Chen, Junchun, et al.
Publicado: (2022)

Intra-articular injection of placental mesenchymal stromal cells ameliorates pain and cartilage anabolism/catabolism in knee osteoarthritis
por: Fan, Mengqiang, et al.
Publicado: (2022)

Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization
por: Zhou, Xin, et al.
Publicado: (2022)

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
por: Leder, Benjamin Z
Publicado: (2018)

Phytochemical Analysis, Antioxidant and Bone Anabolic Effects of Blainvillea acmella (L.) Philipson
por: Abdul Rahim, Rohanizah, et al.
Publicado: (2022)

Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics
por: Ma, Yong-Sheng, et al.
Publicado: (2020)

Patchouli Alcohol Modulates the Pregnancy X Receptor/Toll-like Receptor 4/Nuclear Factor Kappa B Axis to Suppress Osteoclastogenesis
por: Lu, Qian, et al.
Publicado: (2021)

Intra-Articular Injection of Adipose-Derived Stem Cells Ameliorates Pain and Cartilage Anabolism/Catabolism in Osteoarthritis: Preclinical and Clinical Evidences
por: Yan, Bo, et al.
Publicado: (2022)

Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures
por: Ho, Mao-Wang, et al.
Publicado: (2021)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
por: Zhan, Yunfei, et al.
Publicado: (2020)

CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis via Modulating RANKL and ROS Signaling Pathways
por: Li, Jing, et al.
Publicado: (2022)

Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis
por: Dou, Ce, et al.
Publicado: (2021)

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis
por: Lu, Junjie, et al.
Publicado: (2022)

Romosozumab: a novel bone anabolic treatment option for osteoporosis?
por: Kerschan-Schindl, Katharina
Publicado: (2019)

Polydatin administration attenuates the severe sublesional bone loss in mice with chronic spinal cord injury
por: Zhan, Jiheng, et al.
Publicado: (2022)

Time-Course Changes and Role of Autophagy in Primary Spinal Motor Neurons Subjected to Oxygen-Glucose Deprivation: Insights Into Autophagy Changes in a Cellular Model of Spinal Cord Ischemia
por: Chen, Shudong, et al.
Publicado: (2020)

Review on the protective activity of osthole against the pathogenesis of osteoporosis
por: Chen, Jincai, et al.
Publicado: (2023)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

miRNAs as Novel Biomarkers of Chronic Kidney Injury in Anabolic-Androgenic Steroid Users: An Experimental Study
por: Sessa, Francesco, et al.
Publicado: (2020)

Tauroursodeoxycholic acid alleviates secondary injury in spinal cord injury mice by reducing oxidative stress, apoptosis, and inflammatory response
por: Hou, Yonghui, et al.
Publicado: (2021)

EFMSDTI: Drug-target interaction prediction based on an efficient fusion of multi-source data
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i4e330bkqavib8dal5rkinp2t7